Market Overview

A Peek Into The Market Before The Trading Starts

Related CAT
Benzinga Weekly Preview: Earnings Season Kicks Into High Gear
Morgan Stanley Feels Cautious on Caterpillar Ahead of 1Q14 Earnings
Stock Futures Tick Up on Encouraging Factory Data (Fox Business)
Related ISIS
Aegerion Shares Up on Study Initiation - Analyst Blog
Isis Reports Final Phase 2 Data on ISIS-APOCIII Rx

Pre-open movers US stock futures are higher this morning, as investors are awaiting the ADP national employment report. Futures for the Dow Jones Industrial Average surged 8 points to 14,589.00 and S&P 500 index futures rose 2.10 points to 1,565.80. Nasdaq 100 futures gained 2.75 points to 2,815.00.

A Peek Into Global Markets European markets were lower today. The STOXX Europe 600 Index fell 0.26%, London's FTSE 100 Index dropped 0.46%, French CAC 40 Index declined 0.47% and German DAX 30 index fell 0.26%.

Asian markets ended mostly lower, with Japan's Nikkei Stock Average rising 2.99%, China's Shanghai Composite tumbling 0.11% and Australia's S&P/ASX 200 dropping 0.58%. Hong Kong's Hang Seng fell 0.14% and India's Sensex dipped 1.26%.

Broker Recommendation Analysts at Goldman Sachs downgraded Caterpillar (NYSE: CAT) from “buy” to “neutral.” The target price for Caterpillar has been lowered from $116 to $101.

Caterpillar shares closed at $84.88 yesterday.

Breaking news

  • Isis Pharmaceuticals (NASDAQ: ISIS) announced today that it has initiated a Phase 1 clinical study for ISIS-APOARx, an antisense drug targeting apolipoprotein(a) for the treatment of atherosclerosis. To read the full news, click here.
  • Ferrellgas Partners, L.P. (NYSE: FGP) announced today the acquisition of the propane operation of Western Petroleum of Roosevelt, Utah. To read the full news, click here.
  • The Ensign Group (NASDAQ: ENSG), announced today that it has acquired San Marcos Rehabilitation and Healthcare Center, a 129-bed skilled nursing facility in San Marcos, Texas, The Courtyard Rehabilitation and Healthcare Center, a 56-bed skilled nursing facility in Victoria, Texas, and La Villa Rehabilitation and Healthcare Center, a 152-bed skilled nursing facility also in Victoria, Texas. To read the full news, click here.
  • AstraZeneca (NYSE: AZN) today announced that MedImmune, its global biologics research and development unit, has acquired AlphaCore Pharma, an Ann Arbor, Michigan-based biotechnology company focused on the development of ACP-501, a recombinant human lecithin-cholesterol acyltransferase (LCAT) enzyme. To read the full news, click here.

Posted-In: Goldman Sachs US Stock FuturesNews Futures Global Pre-Market Outlook Markets

 

Most Popular

Related Articles (AZN + CAT)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free